181 related articles for article (PubMed ID: 20492443)
1. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis.
Rosenstein RE; Pandi-Perumal SR; Srinivasan V; Spence DW; Brown GM; Cardinali DP
J Pineal Res; 2010 Aug; 49(1):1-13. PubMed ID: 20492443
[TBL] [Abstract][Full Text] [Related]
2. Melatonin in the eye: implications for glaucoma.
Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP; Rosenstein RE
Exp Eye Res; 2007 Jun; 84(6):1021-30. PubMed ID: 17174303
[TBL] [Abstract][Full Text] [Related]
3. Melatonin: new places in therapy.
Maharaj DS; Glass BD; Daya S
Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
[TBL] [Abstract][Full Text] [Related]
4. Melatonin: a novel neuroprotectant for the treatment of glaucoma.
Belforte NA; Moreno MC; de Zavalía N; Sande PH; Chianelli MS; Keller Sarmiento MI; Rosenstein RE
J Pineal Res; 2010 May; 48(4):353-64. PubMed ID: 20374442
[TBL] [Abstract][Full Text] [Related]
5. Role of melatonin in the eye and ocular dysfunctions.
Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP
Vis Neurosci; 2006; 23(6):853-62. PubMed ID: 17266777
[TBL] [Abstract][Full Text] [Related]
6. Melatonin: Implications for Ocular Disease and Therapeutic Potential.
Scuderi L; Davinelli S; Iodice CM; Bartollino S; Scapagnini G; Costagliola C; Scuderi G
Curr Pharm Des; 2019; 25(39):4185-4191. PubMed ID: 31724508
[TBL] [Abstract][Full Text] [Related]
7. Potential use of melatonergic drugs in analgesia: mechanisms of action.
Srinivasan V; Pandi-Perumal SR; Spence DW; Moscovitch A; Trakht I; Brown GM; Cardinali DP
Brain Res Bull; 2010 Mar; 81(4-5):362-71. PubMed ID: 20005925
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of intraperitoneal vitamin C, aprotinin and melatonin administration on retinal edema during experimental uveitis in the guinea pig.
Kükner AS; Kükner A; Naziroğlu M; Colakoğlu N; Celebi S; Yilmaz T; Aydemir O
Cell Biochem Funct; 2004; 22(5):299-305. PubMed ID: 15338469
[TBL] [Abstract][Full Text] [Related]
9. Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases.
Aranda ML; Fleitas MFG; Dieguez H; Iaquinandi A; Sande PH; Dorfman D; Rosenstein RE
Curr Neuropharmacol; 2017; 15(7):951-962. PubMed ID: 28088912
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and the aging brain.
Bondy SC; Sharman EH
Neurochem Int; 2007 Mar; 50(4):571-80. PubMed ID: 17276551
[TBL] [Abstract][Full Text] [Related]
11. The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential.
Agorastos A; Huber CG
J Pineal Res; 2011 Jan; 50(1):1-7. PubMed ID: 21073517
[TBL] [Abstract][Full Text] [Related]
12. [Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma].
Chesnokova NB; Beznos OV; Lozinskaya NA; Volkova MS; Zaryanova EV; Zefirov NA; Grigoryev AV
Biomed Khim; 2017 Jan; 63(1):75-80. PubMed ID: 28251954
[TBL] [Abstract][Full Text] [Related]
13. Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential.
Crooke A; Huete-Toral F; Martínez-Águila A; Colligris B; Pintor J
Expert Opin Drug Discov; 2012 Oct; 7(10):989-1001. PubMed ID: 22860991
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of melatonin in experimental free radical-related ocular diseases.
Siu AW; Maldonado M; Sanchez-Hidalgo M; Tan DX; Reiter RJ
J Pineal Res; 2006 Mar; 40(2):101-9. PubMed ID: 16441546
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
Attarzadeh A; Hosseini H; Nowroozizadeh S
Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
[TBL] [Abstract][Full Text] [Related]
16. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
Reiter RJ
Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
[TBL] [Abstract][Full Text] [Related]
17. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
Reiter RJ; Tan DX; Manchester LC; Qi W
Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
[TBL] [Abstract][Full Text] [Related]
18. Flare-up rates with bimatoprost therapy in uveitic glaucoma.
Fortuna E; Cervantes-Castañeda RA; Bhat P; Doctor P; Foster CS
Am J Ophthalmol; 2008 Dec; 146(6):876-82. PubMed ID: 19027422
[TBL] [Abstract][Full Text] [Related]
19. Melatonin oxidative stress and neurodegenerative diseases.
Srinivasan V
Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
[TBL] [Abstract][Full Text] [Related]
20. Free radical scavenging and antioxidant activity of allopurinol and oxypurinol in experimental lens-induced uveitis.
Augustin AJ; Böker T; Blumenröder SH; Lutz J; Spitznas M
Invest Ophthalmol Vis Sci; 1994 Oct; 35(11):3897-904. PubMed ID: 7928187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
